SCHEMBL30019214

SCHEMBL30019214

Clc1ncc2ccn(CCc3ccccc3)c2n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RX7 Q99572 1/20 0.41
HTT P42858 1/20 0.41
PTK2 Q05397 1/20 0.40
CYP2D6 P10635 2/20 0.40
CYP2C19 P33261 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
STAT6 P42226 1/20 0.39
ADORA2A P29274 1/20 0.39
PIN1 Q13526 1/20 0.39
JAK2 O60674 3/20 0.38
CDK1 P06493 2/20 0.38
AURKA O14965 1/20 0.38
DCLK1 O15075 1/20 0.38
PDPK1 O15530 1/20 0.38
ROCK2 O75116 1/20 0.38
PRKD3 O94806 1/20 0.38
MAP4K4 O95819 1/20 0.38
EGFR P00533 1/20 0.38
NTRK1 P04629 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13837867 0.86 STAT6 (0.49) P2RX7PTK2STAT6JAK2CDK1
SCHEMBL30019422 0.86 STAT6 (0.41) PTK2STAT6FYNSRCRPS6KA3
SCHEMBL30019380 0.83 KCNH2 (0.42) CYP2C19CYP1A2JAK2CYP2C9HDAC6
SCHEMBL27845067 0.78 RPS6KA3 (0.36) PTK2STAT6RPS6KA3KMT2A
SCHEMBL28793690 0.78 RPS6KA3 (0.33) PTK2STAT6RPS6KA3KMT2A
SCHEMBL30019499 0.78 SIGMAR1 (0.45) PTK2CYP2D6CYP2C19CYP1A2CYP3A4
SCHEMBL28212561 0.78 CYP1A2 (0.47) HTTPTK2CYP2D6CYP2C19CYP1A2
SCHEMBL24150591 0.77 KMO (0.50) JAK2POLBHDAC6
SCHEMBL3712175 0.76 PAK1 (0.35) PTK2STAT6JAK2CDK1AURKA
SCHEMBL4187055 0.75 GLO1 (0.41) HTTKMT2APOLBALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022226290-A1 2-PHENYLAMINO PYRROLOPYRIMIDINES AS ACK1 INHIBITORS H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. (US) 2022-10-27 WO disclosed